目的　观察金纳多 (EGb761 )治疗脑梗死的疗效。方法　将患者分为观察组和对照组。观察组给予金纳多 (EGb761 )2 0ml,对照组给予刺五加 3 0ml,疗程为 2 0～3 0d ,计算患者治疗前后神经功能缺损程度评分 ,进行统计分析。结果　观察组与对照组治疗前后神经功能缺损程度评分明显减少 (P <0 .0 0 1 ) ,两组相比观察组疗效更好。结论　金纳多 (EGb761 )治疗脑梗死安全有效 Objective To observe the curative effect of Ginaton (EGb761) on cerebral infarction. Methods Patients were divided into observation group and control group. The observation group received 200 ml of EGb761 and the control group received 300 ml Acanthopanax senticosus. The course of treatment was 20 to 30 days. The scores of neurological deficits before and after treatment were calculated and statistically analyzed. Results The scores of neurological deficits in observation group and control group were significantly decreased before and after treatment (P <0.01). The two groups were better than the observation group. Conclusions Ginaton (EGb761) is safe and effective in the treatment of cerebral infarction